Compass Therapeutics, Inc. Stock OTC Markets
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
OTC Markets
15:59:57 2021-11-03 EDT
|
5-day change | 1st Jan Change | ||
| 3.550 USD | -10.80% |
|
+32.67% | - |
| Market Cap | 393M 338M 318M 290M 542M 37.36B 544M 3.77B 1.46B 19.03B 1.47B 1.44B 60.29B | P/E 2026 * |
-4.35x | P/E 2027 * | -3.94x |
|---|---|---|---|---|---|
| Enterprise Value | 243M 209M 197M 179M 335M 23.08B 336M 2.33B 900M 11.76B 911M 891M 37.26B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 11.6x |
| Free-Float |
87.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Compass Therapeutics, Inc.
| 1 day | -10.80% |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
CEO | Chief Executive Officer | 65 | 2024-05-27 |
Barry Shin
DFI | Director of Finance/CFO | 54 | 2024-12-08 |
Bing Gong
CTO | Chief Tech/Sci/R&D Officer | 50 | 2025-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
BRD | Director/Board Member | 65 | 2013-12-31 |
Phil Ferneau
BRD | Director/Board Member | 64 | 2014-12-31 |
Carl Gordon
CHM | Chairman | 61 | 2014-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.80% | +32.67% | - | - | 393M | |
| -0.94% | -0.71% | +45.60% | +103.25% | 68.52B | |
| -0.81% | -5.50% | +31.47% | +75.35% | 62.88B | |
| +3.13% | +1.71% | -12.50% | +390.48% | 28.13B | |
| -2.74% | -6.55% | +26.01% | +10.96% | 25.56B | |
| -0.54% | -5.47% | -3.88% | -18.31% | 24.65B | |
| -1.55% | -4.05% | +19.16% | -18.67% | 19.81B | |
| -4.27% | +3.07% | +211.22% | +362.48% | 17.69B | |
| -1.37% | -4.71% | -5.41% | +506.15% | 14.66B | |
| +1.14% | -0.34% | +52.38% | +163.82% | 14.45B | |
| Average | -1.82% | -1.63% | +40.45% | +175.06% | 30.71B | |
| Weighted average by Cap. | -0.70% | -1.87% | +36.60% | +139.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 22.39M 19.27M 18.14M 16.53M 30.93M 2.13B 31.06M 215M 83.11M 1.09B 84.09M 82.26M 3.44B |
| Net income | -94.04M -80.92M -76.2M -69.43M -130M -8.95B -130M -903M -349M -4.56B -353M -345M -14.44B | -110M -94.51M -88.99M -81.08M -152M -10.45B -152M -1.05B -408M -5.32B -412M -403M -16.87B |
| Net Debt | -150M -129M -122M -111M -207M -14.27B -208M -1.44B -557M -7.27B -563M -551M -23.04B | -133M -114M -108M -98.19M -184M -12.66B -184M -1.28B -494M -6.45B -499M -489M -20.43B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CMPX Stock
- CMPX Stock
Select your edition
All financial news and data tailored to specific country editions
